SHL Telemedicine Ltd.
SHLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.5% | -3.3% | 19% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.4% | 44.3% | 46.1% | 49.6% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -32% | 5.3% | 16% | -14.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -49.5% | -12.4% | -0.1% | -28.5% |
| EPS Diluted | -1.71 | -0.43 | -0.005 | -1 |
| % Growth | -297.7% | -8,169.2% | 99.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |